![Andrew Maleki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Maleki
Direttore Finanziario/CFO presso
SURROZEN, INC.
Patrimonio netto: 19 533 $ in data 30/09/2026
Profilo
Andrew Maleki is Chief Financial Officer at Surrozen, Inc. since 2025.
Mr. Maleki was Head-Corporate Development at Lassen Therapeutics, Inc. from 2021 to 2025.
Mr. Maleki completed undergraduate studies at Yale University and earned an MBA from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SURROZEN INC 0,01% | 15/06/2026 | 607 ( 0,01% ) | 19 533 $ | 30/09/2026 |
Posizioni attive di Andrew Maleki
| Società | Posizione | Inizio |
|---|---|---|
| SURROZEN, INC. | Direttore Finanziario/CFO | 12/11/2025 |
Precedenti posizioni note di Andrew Maleki
| Società | Posizione | Fine |
|---|---|---|
Lassen Therapeutics 1, Inc.
 Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Corporate Officer/Principal | 01/10/2025 |
Formazione di Andrew Maleki
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
15
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
